Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients

Lancet. 1998 Jun 6;351(9117):1701-2. doi: 10.1016/S0140-6736(05)77739-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Alemtuzumab
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / pharmacology
  • Antibodies, Neoplasm / therapeutic use*
  • Cadaver
  • Cyclosporine / administration & dosage*
  • Female
  • Humans
  • Immune Tolerance*
  • Immunosuppressive Agents / administration & dosage*
  • Kidney Transplantation / immunology*
  • Lymphocytes / drug effects
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Immunosuppressive Agents
  • Alemtuzumab
  • Cyclosporine